SCHEMBL8673151

SCHEMBL8673151

COc1ccc(Cc2sc3cc(OC)ccc3c2C(=O)c2ccc(OCCN3CCCCC3)cc2)cc1

nearest known ligand 0.79

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 17/20 0.79
ESR2 Q92731 17/20 0.79
ENPP3 O14638 2/20 0.63
ENPP1 P22413 2/20 0.63
MEN1 O00255 1/20 0.58
PLD2 O14939 1/20 0.58
KDM1A O60341 1/20 0.58
NR1I2 O75469 1/20 0.58
USP2 O75604 1/20 0.58
ALDH1A1 P00352 1/20 0.58
C5 P01031 1/20 0.58
LMNA P02545 1/20 0.58
TP53 P04637 1/20 0.58
FYN P06241 1/20 0.58
PGR P06401 1/20 0.58
CYP3A4 P08684 1/20 0.58
ADRA2A P08913 1/20 0.58
ADORA3 P0DMS8 1/20 0.58
CYP2D6 P10635 1/20 0.58
MAPT P10636 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8671067 0.96 ESR1 (0.87) ESR1ESR2MEN1PLD2KDM1A
SCHEMBL5826488 0.95 ESR1 (0.73) ESR1ESR2ENPP3ENPP1
SCHEMBL8676838 0.88 ESR1 (1.00) ESR1ESR2MEN1PLD2KDM1A
SCHEMBL4822091 0.87 ESR1 (0.67) ESR1ESR2ENPP3ENPP1
SCHEMBL1665661 0.86 ESR1 (1.00) ESR1ESR2ENPP3ENPP1MEN1
Bromide SCHEMBL1665326 0.85 ESR1 (0.98) ESR1ESR2ENPP3ENPP1MEN1
SCHEMBL7632970 0.85 ESR1 (0.98) ESR1ESR2ENPP3ENPP1MEN1
Hydrochloric Acid SCHEMBL2495864 0.85 ESR1 (1.00) ESR1ESR2ENPP3ENPP1MEN1
Hydrochloric Acid SCHEMBL1665332 0.85 ESR1 (1.00) ESR1ESR2ENPP3ENPP1MEN1
SCHEMBL6663935 0.85 ESR1 (0.98) ESR1ESR2ENPP3ENPP1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5728724-A TREATMENT OF POSTMENOPAUSE SYNDROME, OSTEOPOROSIS, CARDIOVASCULAR DISORDERS AND ESTROGEN DEPENDENT CANCER ELI LILLY AND COMPANY (US) 1998-03-17 US claimed
US-5728724-A TREATMENT OF POSTMENOPAUSE SYNDROME, OSTEOPOROSIS, CARDIOVASCULAR DISORDERS AND ESTROGEN DEPENDENT CANCER ELI LILLY AND COMPANY (US) 1998-03-17 US disclosed
EP-0759434-A1 Benzothiophene compounds ELI LILLY AND COMPANY (US) 1997-02-26 EP disclosed